Document ID: chunk:federal_register_of_legislation:F2025C00119:reg:4
Version: federal_register_of_legislation:F2025C00119
Segment Type: reg
Provision Reference: reg 4
Character Range: 6207–7401

4  Simplified outline

      This instrument makes a special arrangement for providing that an adequate supply of pharmaceutical benefits will be available to persons who are receiving treatment for cancer or cancer‑related conditions.
      This instrument provides for medical practitioners to prescribe chemotherapy drugs in doses tailored to the needs of individual patients, rather than prescribing specific pharmaceutical benefits. Suppliers are to supply the prescribed doses of those drugs, with the supply being made from chemotherapy pharmaceutical benefits.
      This instrument also deals with payments for supplies of doses of chemotherapy drugs, with the amount payable being based on the cheapest combination of chemotherapy pharmaceutical benefits that could be used to provide the prescribed doses of drugs.
      This instrument also provides for some kinds of prescription, supply and payment in relation to other pharmaceutical benefits used in treatment for cancer or cancer‑related conditions.
Note: Part VII of the Act, and regulations or other instruments made for the purposes of that Part, have effect subject to this instrument (see subsection 100(3) of the Act).